Bio-Rad Laboratories Class B
BIO.B
5 hedge funds and large institutions have $4.04M invested in Bio-Rad Laboratories Class B in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% less ownership
Funds ownership: 0.59% → 0.58% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
3% less capital invested
Capital invested by funds: $4.16M → $4.04M (-$120K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$1.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$32.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $3.01M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $882K | – | – | – |
|
3
UBS Group
Zurich,
Switzerland
| $135K | – | – | – |
|
|
4
Barclays
London,
United Kingdom
| $5K | -$32.2K | -247 | -86% |
|
|
5
Citigroup
New York
| $2K | +$1.31K | +10 | +500% |
|
BIO.B Hedge Fund Activity: Q1 2016 in Review
5 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q1 2016, worth a combined $4.04M — down 2.9% from $4.16M a quarter earlier.
Fund positioning in BIO.B was balanced in Q1 2016: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Citigroup, adding an estimated $1.31K. The largest seller was Barclays, cutting an estimated $32.2K.
- 5 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $4.04M of Bio-Rad Laboratories Class B stock for Q1 2016, down 2.9% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q1 2016 and 0 closed out.
- The largest Bio-Rad Laboratories Class B buyer in Q1 2016 was Citigroup, an estimated $1.31K added.
- The largest Bio-Rad Laboratories Class B seller in Q1 2016 was Barclays, an estimated $32.2K sold.
Based on aggregated 13F filings for Q1 2016.